VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Jan 01, 2021 To Jan 18, 2021:


Bacillus anthracis (Anthrax)

  1. Su JR, McNeil MM, Welsh KJ, Marquez PL, Ng C, Yan M, Cano MV. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018 Vaccine 2021 [PMID: 33422381]
  2. Ghaderi S, Bozorgmehr MR, Ahmadi M, Tarahomjoo S. Identification of Conformational B-cell Epitopes in Diphtheria Toxin at Varying Temperatures Using Molecular Dynamics Simulations Archives of Razi Institute 75(4):427-437 2021 [PMID: 33403838]

Brucella (Brucellosis)

  1. Socorro Ruiz-Palma MD, Avila-Calderón ED, Aguilera-Arreola MG, López-Merino A, Ruiz EA, Morales-García MDR, López-Villegas EO, Gomez-Lunar Z, Arellano-Reynoso B, Contreras-Rodríguez A. Comparative proteomic analysis of outer membrane vesicles from Brucella suis, Brucella ovis, Brucella canis and Brucella neotomae Archives of microbiology 2021 [PMID: 33432377]
  2. Yin D, Bai Q, Li L, Xu K, Zhang J. Study on immunogenicity and antigenicity of a novel brucella multiepitope recombined protein Biochemical and biophysical research communications 540:37-41 2021 [PMID: 33429198]
  3. Sarangi LN, Tharani N, Polapally S, Rana SK, Thodangala N, Bahekar VS, Prasad A, Chandrasekhar Reddy RV, Surendra KSNL, Gonuguntla HN, Ponnanna NM, Sharma GK. Infectious bovine abortions: observations from an organized dairy herd Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2021 [PMID: 33415719]
  4. Bahadori F, Ghofranipour F, Ghaffarifar S, Ziaei R. Design and validation of brucellosis prevention questionnaire focused on animal vaccination BMC public health 21(1):2 2021 [PMID: 33388047]
  5. Al Jindan R. Scenario of pathogenesis and socioeconomic burden of human brucellosis in Saudi Arabia Saudi journal of biological sciences 28(1):272-279 2021 [PMID: 33424306]
  6. Ren J, Peng Q. A brief review of diagnosis of small ruminants brucellosis Current medicinal chemistry 2020 [PMID: 33390105]

Clostridium botulinum toxin (Botulism)

  1. Ghaderi S, Bozorgmehr MR, Ahmadi M, Tarahomjoo S. Identification of Conformational B-cell Epitopes in Diphtheria Toxin at Varying Temperatures Using Molecular Dynamics Simulations Archives of Razi Institute 75(4):427-437 2021 [PMID: 33403838]

Coronavirus

  1. Antommaria AHM, Monhollen L, Schaffzin JK. An Ethical Analysis of Hospital Visitor Restrictions and Masking Requirements During the COVID-19 Pandemic The Journal of clinical ethics 32(1):35-44 2021 [PMID: 33416516]
  2. Ernst E, Wolfe P, Stahura C, Edwards KA. Technical considerations to development of serological tests for SARS-CoV-2 Talanta 224:121883 2021 [PMID: 33379092]
  3. Sasisekharan V, Pentakota N, Jayaraman A, Tharakaraman K, Wogan GN, Narayanasami U. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset Proceedings of the National Academy of Sciences of the United States of America 118(5) 2021 [PMID: 33446512]
  4. Rappuoli R, De Gregorio E, Del Giudice G, Phogat S, Pecetta S, Pizza M, Hanon E. Vaccinology in the post-COVID-19 era Proceedings of the National Academy of Sciences of the United States of America 118(3) 2021 [PMID: 33431690]
  5. Persson BD, John L, Rafie K, Strebl M, Frängsmyr L, Ballmann MZ, Mindler K, Havenga M, Lemckert A, Stehle T, Carlson LA, Arnberg N. Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46 Proceedings of the National Academy of Sciences of the United States of America 118(3) 2021 [PMID: 33384338]
  6. Pardo-Seco J, Gómez-Carballa A, Bello X, Martinón-Torres F, Salas A. Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics Zoological research 42(1):87-93 2021 [PMID: 33410308]
  7. Ribas A, Garassino MC. At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer Cancer immunology research 2021 [PMID: 33452008]
  8. . Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020 MMWR. Morbidity and mortality weekly report 70(2):46-51 2021 [PMID: 33444297]
  9. Hie B, Zhong ED, Berger B, Bryson B. Learning the language of viral evolution and escape Science (New York, N.Y.) 371(6526):284-288 2021 [PMID: 33446556]
  10. Zhao Q, Gao Y, Xiao M, Huang X, Wu X. Synthesis and immunological evaluation of synthetic peptide based anti-SARS-CoV-2 vaccine candidates Chemical communications (Cambridge, England) 2021 [PMID: 33443248]
  11. Saad N, Moussa S. Immune response to COVID-19 infection: a double-edged sword Immunological medicine :1-10 2021 [PMID: 33444511]
  12. Ferrara F, Vitiello A. Efficacy of synthetic glucocorticoids in COVID-19 endothelites Naunyn-Schmiedeberg's archives of pharmacology 2021 [PMID: 33443616]
  13. Habib MA, Dayyab FM, Iliyasu G, Habib AG. Knowledge, attitude and practice survey of COVID-19 pandemic in Northern Nigeria PloS one 16(1):e0245176 2021 [PMID: 33444360]
  14. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert review of vaccines 2021 [PMID: 33435774]
  15. Sarkar B, Ullah A, Araf Y, Islam NN, Zohora US. Immunoinformatics-guided Designing and In Silico Analysis of Epitope-based Polyvalent Vaccines against Multiple Strains of Human Coronavirus (HCoVs) Expert review of vaccines 2021 [PMID: 33435759]
  16. Chen T, Wang YC, Wu HC. Analyzing the Impact of Vaccine Availability on Alternative Supplier Selection Amid the COVID-19 Pandemic: A cFGM-FTOPSIS-FWI Approach Healthcare (Basel, Switzerland) 9(1) 2021 [PMID: 33451165]
  17. Islam MT, Quispe C, Martorell M, Docea AO, Salehi B, Calina D, Reiner Ž, Sharifi-Rad J. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19 International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition :1-18 2021 [PMID: 33435749]
  18. Datta M, Singh DD, Naqvi AR. Molecular Diagnostic Tools for the Detection of SARS-CoV-2 International reviews of immunology :1-21 2021 [PMID: 33439059]
  19. Chen JS, Alfajaro MM, Chow RD, Wei J, Filler RB, Eisenbarth SC, Wilen CB. Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection Journal of virology 2021 [PMID: 33441348]
  20. Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ, Kimmel M, Van Damme P, de Hoon J, Smith W, Stephenson KE, De Rosa SC, Cohen KW, McElrath MJ, Cormier E, Scheper G, Barouch DH, Hendriks J, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine The New England journal of medicine 2021 [PMID: 33440088]
  21. Feleszko W, Lewulis P, Czarnecki A, Waszkiewicz P. Flattening the Curve of COVID-19 Vaccine Rejection-An International Overview Vaccines 9(1) 2021 [PMID: 33451104]
  22. Isgrò C, Sardanelli AM, Palese LL. Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug Viruses 13(1) 2021 [PMID: 33451132]
  23. Pfaar O, Mahler V. Allergic reactions to COVID-19 -vaccinations - unveiling the secret(s) Allergy 2021 [PMID: 33432606]
  24. Gobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Manne K, Stalls V, Kopp MF, Henderson R, Edwards RJ, Haynes BF, Acharya P. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction Cell reports 34(2):108630 2021 [PMID: 33417835]
  25. Jarjour NN, Masopust D, Jameson SC. T Cell Memory: Understanding COVID-19 Immunity 54(1):14-18 2021 [PMID: 33406391]
  26. Caballero ML, Quirce S. Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines Journal of investigational allergology & clinical immunology :0 2021 [PMID: 33433387]
  27. Kim C, Ryu DK, Lee J, Kim YI, Seo JM, Kim YG, Jeong JH, Kim M, Kim JI, Kim P, Bae JS, Shim EY, Lee MS, Kim MS, Noh H, Park GS, Park JS, Son D, An Y, Lee JN, Kwon KS, Lee JY, Lee H, Yang JS, Kim KC, Kim SS, Woo HM, Kim JW, Park MS, Yu KM, Kim SM, Kim EH, Park SJ, Jeong ST, Yu CH, Song Y, Gu SH, Oh H, Koo BS, Hong JJ, Ryu CM, Park WB, Oh MD, Choi YK, Lee SY. A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein Nature communications 12(1):288 2021 [PMID: 33436577]
  28. Brooks NA, Puri A, Garg S, Nag S, Corbo J, Turabi AE, Kaka N, Zemmel RW, Hegarty PK, Kamat AM. The association of Coronavirus Disease-19 mortality and prior bacille Calmette-Guerin vaccination: a robust ecological analysis using unsupervised machine learning Scientific reports 11(1):774 2021 [PMID: 33436946]
  29. Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity Science (New York, N.Y.) 2021 [PMID: 33436525]
  30. Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A. High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries Vaccines 9(1) 2021 [PMID: 33445581]
  31. Agrawal L, Poullikkas T, Eisenhower S, Monsanto C, Bakku RK, Chen MH, Kalra RS. Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets Antibodies (Basel, Switzerland) 10(1) 2021 [PMID: 33440681]
  32. Ahsan MA, Liu Y, Feng C, Zhou Y, Ma G, Bai Y, Chen M. Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2 Briefings in bioinformatics 2021 [PMID: 33432321]
  33. Kaur A, Bhalla V, Salahuddin M, Rahman SO, Pottoo FH. COVID -19 infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment Current pharmaceutical design 2021 [PMID: 33430745]
  34. Tan S, Chen W, Xiang H, Kong G, Zou L, Wei L. Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis Genes & genomics 2021 [PMID: 33428154]
  35. Anichini G, Gandolfo C, Terrosi C, Fabrizi S, Miceli GB, Savellini GG, Prathyumnan S, Franchi F, Cusi MG. Antibody response to SARS-CoV-2 in infected patients with different clinical outcome Journal of medical virology 2021 [PMID: 33427302]
  36. Chiem K, Morales Vasquez D, Park JG, Platt RN, Anderson T, Walter MR, Kobie JJ, Ye C, Martinez-Sobrido L. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes Journal of virology 2021 [PMID: 33431557]
  37. Xiao T, Lu J, Zhang J, Johnson RI, McKay LGA, Storm N, Lavine CL, Peng H, Cai Y, Rits-Volloch S, Lu S, Quinlan BD, Farzan M, Seaman MS, Griffiths A, Chen B. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent Nature structural & molecular biology 2021 [PMID: 33432247]
  38. Shaibu JO, Onwuamah CK, James AB, Okwuraiwe AP, Amoo OS, Salu OB, Ige FA, Liboro G, Odewale E, Okoli LC, Ahmed RA, Achanya D, Adesesan A, Amuda OA, Sokei J, Oyefolu BAO, Salako BL, Omilabu SA, Audu RA. Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria PloS one 16(1):e0243271 2021 [PMID: 33428634]
  39. Mellet J, Pepper MS. A COVID-19 Vaccine: Big Strides Come with Big Challenges Vaccines 9(1) 2021 [PMID: 33440895]
  40. Caminati M, Guarnieri G, Senna G. Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine? Vaccines 9(1) 2021 [PMID: 33440794]
  41. Suzuki YJ, Gychka SG. SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines Vaccines 9(1) 2021 [PMID: 33440640]
  42. Rosa V, Ho D, Sabino-Silva R, Siqueira WL, Silikas N. Fighting viruses with materials science: Prospects for antivirus surfaces, drug delivery systems and artificial intelligence Dental materials : official publication of the Academy of Dental Materials 2021 [PMID: 33441249]
  43. Rahimi G, Rahimi B, Panahi M, Abkhiz S, Saraygord-Afshari N, Milani M, Alizadeh E. An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses International immunopharmacology 92:107365 2021 [PMID: 33440306]
  44. Rahman MM, Hasan M, Ahmed A. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients Reviews in medical virology 2021 [PMID: 33426683]
  45. Lopez-Santamarina A, Lamas A, Del Carmen Mondragón A, Cardelle-Cobas A, Regal P, Rodriguez-Avila JA, Miranda JM, Franco CM, Cepeda A. Probiotic Effects against Virus Infections: New Weapons for an Old War Foods (Basel, Switzerland) 10(1) 2021 [PMID: 33435315]
  46. Mattoli S. Filling the Gap Until Full Vaccine Deployment in the War on Coronavirus Disease-19 Infectious diseases and therapy 2021 [PMID: 33420955]
  47. Müller C, Obermann W, Karl N, Wendel HG, Taroncher-Oldenburg G, Pleschka S, Hartmann RK, Grünweller A, Ziebuhr J. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo Antiviral research 186:105012 2021 [PMID: 33422611]
  48. Hahn G, Lee S, Weiss ST, Lange C. Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus Genetic epidemiology 2021 [PMID: 33415739]
  49. Nunes MC, Cutland CL, Klugman KP, Madhi SA. Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV mBio 12(1) 2021 [PMID: 33419872]
  50. Rao PPN, Pham AT, Shakeri A, El Shatshat A, Zhao Y, Karuturi RC, Hefny AA. Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection Pharmaceuticals (Basel, Switzerland) 14(1) 2021 [PMID: 33430081]
  51. Chagas SCC, Moreira FSM, Barbosa ICF, Leal Júnior OS, Leal LB, Santana DP. Critical analysis on the use of cholecalciferol as a COVID-19 intervention: a narrative review Sao Paulo medical journal = Revista paulista de medicina 2021 [PMID: 33439960]
  52. Fakhar Z, Khan S, AlOmar SY, Alkhuriji A, Ahmad A. ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19 Scientific reports 11(1):234 2021 [PMID: 33420186]
  53. Pushparajah D, Jimenez S, Wong S, Alattas H, Nafissi N, Slavcev RA. Advances in gene-based vaccine platforms to address the COVID-19 pandemic Advanced drug delivery reviews 2021 [PMID: 33422546]
  54. Pollet J, Chen WH, Strych U. Recombinant protein vaccines, a proven approach against coronavirus pandemics Advanced drug delivery reviews 170:71-82 2021 [PMID: 33421475]
  55. Olney AM, Smith J, Sen S, Thomas F, Unwin HJT. Estimating the Effect of Social Distancing Interventions on COVID-19 in the United States American journal of epidemiology 2021 [PMID: 33406533]
  56. Zhou N, Bao J, Ning Y. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection BMC bioinformatics 22(1):18 2021 [PMID: 33413085]
  57. Li F, Michelson AP, Foraker R, Zhan M, Payne PRO. Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2 BMC medical informatics and decision making 21(1):15 2021 [PMID: 33413329]
  58. Agley J, Xiao Y. Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science BMC public health 21(1):89 2021 [PMID: 33413219]
  59. Chin J, Zhou Y, Chen CL, Lomiguen CM, McClelland S, Lee-Wong M. Influenza Vaccination Quality Improvement as a Model for COVID-19 Prophylaxis Cureus 13(1):e12549 2021 [PMID: 33437559]
  60. Ward D, Higgins M, Phelan JE, Hibberd ML, Campino S, Clark TG. An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets Genome medicine 13(1):4 2021 [PMID: 33413610]
  61. Carbone M, Lednicky J, Xiao SY, Venditti M, Bucci E. Coronavirus Infectious Disease Epidemic (COVID-19): where we are, what can be done and hope for Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 [PMID: 33422679]
  62. Shi Y, Shi J, Sun L, Tan Y, Wang G, Guo F, Hu G, Fu Y, Fu ZF, Xiao S, Peng G. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins Journal of virology 2021 [PMID: 33414160]
  63. Rubin EJ, Baden LR, Lee TH, Morrissey S. Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout The New England journal of medicine 384(1):e13 2021 [PMID: 33406335]
  64. Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer B, McDonald RH, Fitzpatrick MC, Galvani AP. Optimal COVID-19 quarantine and testing strategies Nature communications 12(1):356 2021 [PMID: 33414470]
  65. Lee BY, Bartsch SM, Ferguson MC, Wedlock PT, O'Shea KJ, Siegmund SS, Cox SN, McKinnell JA. The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection PLoS computational biology 17(1):e1008470 2021 [PMID: 33411742]
  66. Anaki D, Sergay J. Predicting health behavior in response to the coronavirus disease (COVID-19): Worldwide survey results from early March 2020 PloS one 16(1):e0244534 2021 [PMID: 33411827]
  67. Incognito AV, Millar PJ, Pyle WG. Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19 American journal of physiology. Lung cellular and molecular physiology 2021 [PMID: 33404365]
  68. Kumar N, Golhar R, Sharma KS, Holloway JL, Sarangi S, Neuhaus I, Walsh AM, Pitluk ZW. Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell™ BMC genomics 22(1):5 2021 [PMID: 33407110]
  69. Eyal N, Lipsitch M. Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2021 [PMID: 33421580]
  70. Patwardhan A, Ohler A. The Flu Vaccination May Have a Protective Effect on the Course of COVID-19 in the Pediatric Population: When Does Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Meet Influenza? Cureus 13(1):e12533 2021 [PMID: 33425565]
  71. Oladipo EK, Ajayi AF, Onile OS, Ariyo OE, Jimah EM, Ezediuno LO, Adebayo OI, Adebayo ET, Odeyemi AN, Oyeleke MO, Oyewole MP, Oguntomi AS, Akindiya OE, Aremu VO, Aboderin DO, Oloke JK. Designing a conserved peptide-based subunit vaccine against SARS-CoV-2 using immunoinformatics approach In silico pharmacology 9(1):8 2021 [PMID: 33425647]
  72. Sarkar JP, Saha I, Seal A, Maity D, Maulik U. Topological analysis for sequence variability: Case study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countriesvin comparison with SARS-CoV-1 and MERS-CoV Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases :104708 2021 [PMID: 33421654]
  73. Inglis TJJ. 2020: the year of living cautiously Journal of medical microbiology 2021 [PMID: 33404382]
  74. Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, Soni D, Das S, Hasan M, Patel M, Senan AM, Gorantla S, McMillan J, Edagwa B, Eisenberg R, Gurumurthy CB, Reid SPM, Punyadeera C, Chang L, Gendelman HE. Pharmacotherapeutics of SARS-CoV-2 Infections Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2021 [PMID: 33403500]
  75. D'Arcangelo G, Distante M, Raso T, Rossetti D, Catassi G, Aloi M. Safety of Biological Therapy in Children With Inflammatory Bowel Disease Journal of pediatric gastroenterology and nutrition Publish Ahead of Print 2021 [PMID: 33416268]
  76. Li DD, Li QH. SARS-CoV-2: vaccines in the pandemic era Military Medical Research 8(1):1 2021 [PMID: 33402220]
  77. Rostad BS, Shah JH, Rostad CA, Jaggi P, Richer EJ, Linam LE, Alazraki AL, Riedesel EL, Milla SS. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19 Pediatric radiology 2021 [PMID: 33404786]
  78. Almansour I, Macadato NC, Alshammari T. Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2 Pharmaceuticals (Basel, Switzerland) 14(1) 2021 [PMID: 33419184]
  79. Hindes J, Bianco S, Schwartz IB. Optimal periodic closure for minimizing risk in emerging disease outbreaks PloS one 16(1):e0244706 2021 [PMID: 33406106]
  80. Alshaabi T, Arnold MV, Minot JR, Adams JL, Dewhurst DR, Reagan AJ, Muhamad R, Danforth CM, Dodds PS. How the world's collective attention is being paid to a pandemic: COVID-19 related n-gram time series for 24 languages on Twitter PloS one 16(1):e0244476 2021 [PMID: 33406101]
  81. Ribeiro TB, Mazotti TA, Silva NAO, Stein AT, Diaz-Quijano FA, Melo DO. Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil Revista brasileira de epidemiologia = Brazilian journal of epidemiology 23:e200104 2021 [PMID: 33439937]
  82. Majumder J, Minko T. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19 The AAPS journal 23(1):14 2021 [PMID: 33400058]
  83. Cutts FT, Ferrari MJ, Krause LK, Tatem AJ, Mosser JF. Vaccination strategies for measles control and elimination: time to strengthen local initiatives BMC medicine 19(1):2 2021 [PMID: 33397366]
  84. Herzog LM, Norheim OF, Emanuel EJ, McCoy MS. Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access BMJ (Clinical research ed.) 372:m4853 2021 [PMID: 33402340]
  85. Prakash O, Solanki B, Sheth JK, Joshi B, Kadam M, Vyas S, Shukla A, Tiwari H, Rathod S, Rajput A, Trivedi T, Ramanuj V, Solanki A. Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study BMJ open 11(1):e044101 2021 [PMID: 33402413]
  86. Tong A, Baumgart A, Evangelidis N, Viecelli AK, Carter SA, Azevedo LC, Cooper T, Bersten A, Cervantes L, Chew DP, Crowe S, Douglas IS, Flemyng E, Elliott JH, Hannan E, Horby P, Howell M, Ju A, Lee J, Lorca E, Lynch D, Manera KE, Marshall JC, Gonzalez AM, McKenzie A, Mehta S, Mer M, Morris AC, Needham DM, Nseir S, Povoa P, Reid M, Sakr Y, Shen N, Smyth AR, Simpson AJ, Snelling T, Strippoli GFM, Teixeira-Pinto A, Torres A, Turner T, Webb S, Williamson PR, Woc-Colburn L, Zhang J, Craig JC. Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery Critical care medicine Publish Ahead of Print 2021 [PMID: 33400475]
  87. Gostin LO. A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden JAMA 325(1):17-18 2021 [PMID: 33399836]
  88. Marsh GA, McAuley AJ, Brown S, Pharo EA, Crameri S, Au GG, Baker ML, Barr J, Bergfeld J, Bruce M, Burkett K, Durr PA, Holmes C, Izzard L, Layton R, Lowther S, Neave MJ, Poole T, Riddell S, Rowe B, Soldani E, Stevens V, Suen W, Sundaramoorthy V, Tachedjian M, Todd S, Trinidad L, Williams SM, Druce JD, Drew TW, Vasan SS. In vitro Characterisation of SARS-CoV-2 and Susceptibility of Domestic Ferrets (Mustela putorius furo) Transboundary and emerging diseases 2021 [PMID: 33400387]
  89. Cao XT. [Immunological research of COVID-19 and emerging infectious diseases] Zhonghua yi xue za zhi 101(1):1-6 2021 [PMID: 33423443]
  90. Lee C, Choi WJ. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective Archives of pharmacal research 2021 [PMID: 33398692]
  91. Ghodake GS, Shinde SK, Kadam AA, Saratale RG, Saratale GD, Syed A, Elgorban AM, Marraiki N, Kim DY. Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures Biosensors & bioelectronics 177:112969 2021 [PMID: 33434780]
  92. Timberlake DT, Strothman K, Grayson MH. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019 Current opinion in allergy and clinical immunology Publish Ahead of Print 2021 [PMID: 33399389]
  93. Furtado GE, Letieri RV, Caldo A, Sardão V, Teixeira AM, de Barros MP, Vieira RP, Bachi ALL. Sustaining efficient immune functions with regular physical exercise in the COVID-19 era and beyond European journal of clinical investigation :e13485 2021 [PMID: 33393082]
  94. Ortega Rodríguez NR, Audícana Berasategui MT, de la Hoz Caballer B, Valero Santiago A. The century of mRNA vaccines: COVID-19 vaccines and allergy Journal of investigational allergology & clinical immunology :0 2021 [PMID: 33393485]
  95. Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, Slayton RB, Biggerstaff M, Butler JC. SARS-CoV-2 Transmission From People Without COVID-19 Symptoms JAMA network open 4(1):e2035057 2021 [PMID: 33410879]
  96. Angulo FJ, Finelli L, Swerdlow DL. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys JAMA network open 4(1):e2033706 2021 [PMID: 33399860]
  97. Gokada MR, Pasupuleti VR, Bollikolla HB. A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19 Mini reviews in medicinal chemistry 2021 [PMID: 33397236]
  98. Ryan KA, Bewley KR, Fotheringham SA, Slack GS, Brown P, Hall Y, Wand NI, Marriott AC, Cavell BE, Tree JA, Allen L, Aram MJ, Bean TJ, Brunt E, Buttigieg KR, Carter DP, Cobb R, Coombes NS, Findlay-Wilson SJ, Godwin KJ, Gooch KE, Gouriet J, Halkerston R, Harris DJ, Hender TH, Humphries HE, Hunter L, Ho CMK, Kennard CL, Leung S, Longet S, Ngabo D, Osman KL, Paterson J, Penn EJ, Pullan ST, Rayner E, Skinner O, Steeds K, Taylor I, Tipton T, Thomas S, Turner C, Watson RJ, Wiblin NR, Charlton S, Hallis B, Hiscox JA, Funnell S, Dennis MJ, Whittaker CJ, Catton MG, Druce J, Salguero FJ, Carroll MW. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity Nature communications 12(1):81 2021 [PMID: 33398055]
  99. Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, McKay R, Bennett K, Mason L, Gibson-Miller J, Levita L, Martinez AP, Stocks TVA, Karatzias T, Hyland P. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom Nature communications 12(1):29 2021 [PMID: 33397962]
  100. Joachimiak MP. Zinc against COVID-19? Symptom surveillance and deficiency risk groups PLoS neglected tropical diseases 15(1):e0008895 2021 [PMID: 33395417]
  101. Senthilraja M. Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus SLAS technology :2472630320983813 2021 [PMID: 33390088]
  102. Suda Y, Miyazaki A, Miyazawa K, Shibahara T, Ohashi S. Systemic and intestinal porcine epidemic diarrhea virus-specific antibody response and distribution of antibody-secreting cells in experimentally infected conventional pigs Veterinary research 52(1):2 2021 [PMID: 33397461]
  103. Zobba R, Visco S, Sotgiu F, Pinna Parpaglia ML, Pittau M, Alberti A. Molecular survey of parvovirus, astrovirus, coronavirus, and calicivirus in symptomatic dogs Veterinary research communications 2021 [PMID: 33392909]
  104. Zheng Y, Larragoite ET, Williams ESCP, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Coiras M, Rondina MT, Spivak AM, Planelles V. Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions Virology journal 18(1):1 2021 [PMID: 33397387]
  105. Chen J, Huang R, Nie Y, Wen X, Wu Y. Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19 Virologica Sinica 2021 [PMID: 33394351]
  106. Bhattacharjee A, Saha M, Halder A, Debnath A, Mukherjee O. Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19 Current microbiology 2021 [PMID: 33392670]
  107. Anwar MM. Immunotherapies and COVID-19 related Neurological manifestations: A Comprehensive Review Article Journal of immunoassay & immunochemistry :1-16 2021 [PMID: 33393415]
  108. Banday AZ, Arul A, Vignesh P, Singh MP, Goyal K, Singh S. Kawasaki disease and influenza-new lessons from old associations Clinical rheumatology 2021 [PMID: 33387094]
  109. Ishigami J, Kou M, Ding N, Matsushita K. Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention Current epidemiology reports :1-8 2021 [PMID: 33425654]
  110. Blanco A, Ojembarrena FB, Clavo B, Negro C. Ozone potential to fight against SAR-COV-2 pandemic: facts and research needs Environmental science and pollution research international 2021 [PMID: 33389580]
  111. Karagöz IK, Munk MR, Kaya M, Rückert R, Yıldırım M, Karabaş L. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions? Experimental eye research 203:108433 2021 [PMID: 33400927]
  112. Haji Esmaeil Memar E, Pourakbari B, Gorgi M, Sharifzadeh Ekbatani M, Navaeian A, Khodabandeh M, Mahmoudi S, Mamishi S. COVID-19 and congenital heart disease: a case series of nine children World journal of pediatrics : WJP 2021 [PMID: 33387256]
  113. Fishman J. Commentary: The Advisory Committee on Immunization Practices' ethical principles for allocating initial supplies of COVID-19 vaccine - United States, 2020 American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21(1):419 2021 [PMID: 33382540]
  114. Luk HN, Yang YL, Huang CH, Su IM, Tsai PB. Application of Plastic Sheet Barrier and Video Intubating Stylet to Protect Tracheal Intubators During Coronavirus Disease 2019 Pandemic: A Taiwan Experience Cell transplantation 30:963689720987527 2021 [PMID: 33426911]
  115. Li JG, Xu H. Chinese Medicine in Fighting against Covid-19: Role and Inspiration Chinese journal of integrative medicine 27(1):3-6 2021 [PMID: 33420601]
  116. Ong E, Huang X, Pearce R, Zhang Y, He Y. Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering Computational and structural biotechnology journal 19:518-529 2021 [PMID: 33398234]
  117. Rehman MFU, Fariha C, Anwar A, Shahzad N, Ahmad M, Mukhtar S, Farhan Ul Haque M. Novel coronavirus disease (COVID-19) pandemic: A recent mini review Computational and structural biotechnology journal 19:612-623 2021 [PMID: 33398233]
  118. Wahab S, Ahmad I, Irfan S, Baig MH, Farouk AE, Dong JJ. Use of Natural Compounds as a potential therapeutic agent against COVID-19 Current pharmaceutical design 2021 [PMID: 33388014]
  119. Awadasseid A, Wu Y, Tanaka Y, Zhang W. Current advances in the development of SARS-CoV-2 vaccines International journal of biological sciences 17(1):8-19 2021 [PMID: 33390829]
  120. Han J, Sun J, Zhang G, Chen H. DCs-based therapies: potential strategies in severe SARS-CoV-2 infection International journal of medical sciences 18(2):406-418 2021 [PMID: 33390810]
  121. Liu HQ, Yuan B, An YW, Chen KJ, Hu Q, Hu XP, Zhao J, Dong Y, Chen YX, Li WX, Sun CQ, Wang JC, Wang C, Song S. Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period International journal of medical sciences 18(2):347-355 2021 [PMID: 33390803]
  122. Dubanevics I, McLeish TCB. Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease Journal of the Royal Society, Interface 18(174):20200591 2021 [PMID: 33402024]
  123. Aydogdu MO, Altun E, Chung E, Ren G, Homer-Vanniasinkam S, Chen B, Edirisinghe M. Surface interactions and viability of coronaviruses Journal of the Royal Society, Interface 18(174):20200798 2021 [PMID: 33402019]
  124. Jahan R, Mishra B, Behera B, Mohapatra PR, Praharaj AK. Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases Lung India : official organ of Indian Chest Society 38(1):53-58 2021 [PMID: 33402638]
  125. Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020 MMWR. Morbidity and mortality weekly report 69(5152):1653-1656 2021 [PMID: 33382675]
  126. Zomahoun DJ, Burman AL, Snider CJ, Chauvin C, Gardner T, Lickness JS, Ahmed JA, Diop O, Gerber S, Anand A. Impact of COVID-19 Pandemic on Global Poliovirus Surveillance MMWR. Morbidity and mortality weekly report 69(5152):1648-1652 2021 [PMID: 33382673]
  127. Dooling K, Marin M, Wallace M, McClung N, Chamberland M, Lee GM, Talbot HK, Romero JR, Bell BP, Oliver SE. The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020 MMWR. Morbidity and mortality weekly report 69(5152):1657-1660 2021 [PMID: 33382671]
  128. . AstraZeneca joins Russia to boost coronavirus vaccine Nature biotechnology 39(1):11 2021 [PMID: 33432222]
  129. Wagar LE, Salahudeen A, Constantz CM, Wendel BS, Lyons MM, Mallajosyula V, Jatt LP, Adamska JZ, Blum LK, Gupta N, Jackson KJL, Yang F, Röltgen K, Roskin KM, Blaine KM, Meister KD, Ahmad IN, Cortese M, Dora EG, Tucker SN, Sperling AI, Jain A, Davies DH, Felgner PL, Hammer GB, Kim PS, Robinson WH, Boyd SD, Kuo CJ, Davis MM. Modeling human adaptive immune responses with tonsil organoids Nature medicine 27(1):125-135 2021 [PMID: 33432170]
  130. Karpiński TM, Ożarowski M, Seremak-Mrozikiewicz A, Wolski H, Wlodkowic D. The 2020 race towards SARS-CoV-2 specific vaccines Theranostics 11(4):1690-1702 2021 [PMID: 33408775]
  131. Lentine KL, Mannon RB, Josephson MA. Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic American journal of kidney diseases : the official journal of the National Kidney Foundation 2020 [PMID: 33388404]
  132. Mishra CB, Pandey P, Sharma RD, Malik MZ, Mongre RK, Lynn AM, Prasad R, Jeon R, Prakash A. Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach Briefings in bioinformatics 2020 [PMID: 33386025]
  133. Abedi F, Rezaee R, Hayes AW, Nasiripour S, Karimi G. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? Cell cycle (Georgetown, Tex.) :1-11 2020 [PMID: 33382348]
  134. Harahap Y, Diptasaadya R, Purwanto DJ. Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review Drug design, development and therapy 14:5757-5771 2020 [PMID: 33414636]
  135. O'Leary VB, Dolly OJ, Höschl C, Černa M, Ovsepian SV. Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus International journal of molecular sciences 22(1) 2020 [PMID: 33396557]
  136. Rubin EJ, Baden LR, Morrissey S. Audio Interview: A Look at Covid-19 Prevention and Care in 2020 The New England journal of medicine 383(27):e147 2020 [PMID: 33382936]
  137. Zhang H, Yang Y, Li J, Wang M, Saravanan KM, Wei J, Tze-Yang Ng J, Tofazzal Hossain M, Liu M, Zhang H, Ren X, Pan Y, Peng Y, Shi Y, Wan X, Liu Y, Wei Y. A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro PLoS computational biology 16(12):e1008489 2020 [PMID: 33382685]
  138. Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, Rigby S, Williams SV, Bermingham WH, Kellam P, Maher J, Shields AM, Amirthalingam G, Peacock SJ, Ismail SA. Antibody response to SARS-CoV-2 infection in humans: A systematic review PloS one 15(12):e0244126 2020 [PMID: 33382764]
  139. Ellebedy A, Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, Hansen L, Haile A, Klebert M, Pusic I, O'Halloran J, Presti R. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans Research square 2020 [PMID: 33398264]
  140. Faruque Ahmad M. A Novel Perspective Approach to Explore Pros and Cons of Face Mask in Prevention the Spread of SARS-CoV-2 and other pathogens Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2020 [PMID: 33398228]
  141. Tumban E. Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval Viruses 13(1) 2020 [PMID: 33396343]
  142. Manolis AS, Manolis TA, Manolis AA, Melita H. Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down Current opinion in cardiology Publish Ahead of Print 2020 [PMID: 33395080]
  143. Pashaei Y. Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic Drug discoveries & therapeutics 2020 [PMID: 33390567]
  144. Farshbaf A, Mohtasham N, Zare R, Mohajertehran F, Rezaee SA. Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities Journal of oral biology and craniofacial research 2020 [PMID: 33398242]
  145. Massacci A, Sperandio E, D'Ambrosio L, Maffei M, Palombo F, Aurisicchio L, Ciliberto G, Pallocca M. Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants Journal of translational medicine 18(1):494 2020 [PMID: 33380328]
  146. Motta M. Can a COVID-19 vaccine live up to Americans' expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions Social science & medicine (1982) :113642 2020 [PMID: 33414031]
  147. Lin C, Tu P, Beitsch LM. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review Vaccines 9(1) 2020 [PMID: 33396832]
  148. Mahmood N, Nasir SB, Hefferon K. Plant-Based Drugs and Vaccines for COVID-19 Vaccines 9(1) 2020 [PMID: 33396667]
  149. Dimonaco NJ, Salavati M, Shih BB. Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations Viruses 13(1) 2020 [PMID: 33396801]
  150. Sauer MM, Tortorici MA, Park YJ, Walls AC, Homad L, Acton O, Bowen J, Wang C, Xiong X, de van der Schueren W, Quispe J, Hoffstrom BG, Bosch BJ, McGuire AT, Veesler D. Structural basis for broad coronavirus neutralization bioRxiv : the preprint server for biology 2020 [PMID: 33398277]
  151. Yan Y, Chang L, Luo W, Liu J, Guo F, Wang L. Comparison of Seven Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Detection Reagents with Pseudovirus as Quality Control Material The Journal of molecular diagnostics : JMD 2020 [PMID: 33383210]
  152. Sun Y, Yin Y, Gong L, Liang Z, Zhu C, Ren C, Zheng N, Zhang Q, Liu H, Liu W, You F, Lu D, Lin Z. Manganese nanodepot augments host immune response against coronavirus Nano research :1-13 2020 [PMID: 33391623]
  153. Ishigaki H, Nakayama M, Kitagawa Y, Nguyen CT, Hayashi K, Shiohara M, Gotoh B, Itoh Y. Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques Virology 554:97-9105 2020 [PMID: 33412411]
  154. Machado BAS, Hodel KVS, Barbosa-Júnior VG, Soares MBP, Badaró R. The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature Viruses 13(1) 2020 [PMID: 33383888]
  155. Rovnak J, St Clair LA, McAlister C, Ogbu CP, Smolenske J, Cohrs RJ, Perera R. The 20th Anniversary Meeting of the Rocky Mountain Virology Association Viruses 13(1) 2020 [PMID: 33383821]
  156. Riepler L, Rössler A, Falch A, Volland A, Borena W, von Laer D, Kimpel J. Comparison of Four SARS-CoV-2 Neutralization Assays Vaccines 9(1) 2020 [PMID: 33379160]
  157. Zhong Y, Clapham HE, Aishworiya R, Chua YX, Mathews J, Ong M, Wang J, Murugasu B, Chiang WC, Lee BW, Chin HL. Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore Vaccine 2020 [PMID: 33414050]
  158. Li Q, Lu H. Latest updates on COVID-19 vaccines Bioscience trends 2020 [PMID: 33390384]
  159. Kelly JA, Woodside MT, Dinman JD. Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target Virology 554:75-82 2020 [PMID: 33387787]
  160. Moore KM, Suthar MS. Comprehensive analysis of COVID-19 during pregnancy Biochemical and biophysical research communications 2020 [PMID: 33384142]
  161. Valcourt EJ, Manguiat K, Robinson A, Chen JC, Dimitrova K, Philipson C, Lamoureux L, McLachlan E, Schiffman Z, Drebot MA, Wood H. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Diagnostic microbiology and infectious disease 99(4):115294 2020 [PMID: 33387896]
  162. Guimarães VHA, Leandro MO, Cassiano C, Marques ALP, Motta C, Freitas-Silva AL, de Sousa MAD, Silveira LAM, Pardi TC, Gazotto FC, Silva MV, Rodrigues V Jr, Rodrigues WF, Oliveira CJF. Population's Knowledge About COVID-19: A Cross-Sectional Web-Based Study in Brazil JMIR public health and surveillance 2020 [PMID: 33400684]
  163. Rochman ND, Wolf YI, Koonin EV. Substantial Impact of Post Vaccination Contacts on Cumulative Infections during Viral Epidemics medRxiv : the preprint server for health sciences 2020 [PMID: 33398300]
  164. Gu T, Yao L, Meng X, Graff JC, Thomason D, Li J, Dong W, Jiao Y, Aleya L, Maida M, Wang CY, Zangerl B, Genini S, Ray K, Goldman E, Ji J, Alexandrov AV, Sun D, Gu W, Wang Y. A cost-effective plan for global testing - an infection rate stratified, algorithm guided, multiple-level, continuously pooled testing strategy The Science of the total environment 765:144251 2020 [PMID: 33387925]
  165. Gorman S, Weller RB. Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update Frontiers in cardiovascular medicine 7:616527 2020 [PMID: 33426009]
  166. Zhao J, Zhao S, Ou J, Zhang J, Lan W, Guan W, Wu X, Yan Y, Zhao W, Wu J, Chodosh J, Zhang Q. COVID-19: Coronavirus Vaccine Development Updates Frontiers in immunology 11:602256 2020 [PMID: 33424848]
  167. Karaderi T, Bareke H, Kunter I, Seytanoglu A, Cagnan I, Balci D, Barin B, Hocaoglu MB, Rahmioglu N, Asilmaz E, Taneri B. Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity Frontiers in immunology 11:586111 2020 [PMID: 33414783]
  168. Bierig T, Collu G, Blanc A, Poghosyan E, Benoit RM. Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct Frontiers in bioengineering and biotechnology 8:618615 2020 [PMID: 33409271]
  169. Lee E, Sandgren K, Duette G, Stylianou VV, Khanna R, Eden JS, Blyth E, Gottlieb D, Cunningham AL, Palmer S. Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity Journal of virology 2020 [PMID: 33443088]
  170. Shiakolas AR, Kramer KJ, Wrapp D, Richardson SI, Schäfer A, Wall S, Wang N, Janowska K, Pilewski KA, Venkat R, Parks R, Manamela NP, Raju N, Fechter EF, Holt CM, Suryadevara N, Chen RE, Martinez DR, Nargi RS, Sutton RE, Ledgerwood JE, Graham BS, Diamond MS, Haynes BF, Acharya P, Carnahan RH, Crowe JE, Baric RS, Morris L, McLellan JS, Georgiev IS. Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions bioRxiv : the preprint server for biology 2020 [PMID: 33398266]
  171. Melgaço JG, Brito E Cunha D, Azamor T, da Silva AMV, Tubarão LN, Gonçalves RB, Monteiro RQ, Missailidis S, da Costa Neves PC, Ano Bom APD. Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs Journal of immunology research 2020:8827670 2020 [PMID: 33426096]
  172. Galipeau Y, Greig M, Liu G, Driedger M, Langlois MA. Humoral Responses and Serological Assays in SARS-CoV-2 Infections Frontiers in immunology 11:610688 2020 [PMID: 33391281]
  173. Mariano G, Farthing RJ, Lale-Farjat SLM, Bergeron JRC. Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be Frontiers in molecular biosciences 7:605236 2020 [PMID: 33392262]
  174. Abdusalam AAA, Murugaiyah V. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening Frontiers in molecular biosciences 7:603037 2020 [PMID: 33392261]
  175. Hossain MS, Hami I, Sawrav MSS, Rabbi MF, Saha O, Bahadur NM, Rahaman MM. Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape Discoveries (Craiova, Romania) 8(4):e121 2020 [PMID: 33403227]
  176. Pretti MAM, Galvani RG, Vieira GF, Bonomo A, Bonamino MH, Boroni M. Class I HLA Allele Predicted Restricted Antigenic Coverages for Spike and Nucleocapsid Proteins Are Associated With Deaths Related to COVID-19 Frontiers in immunology 11:565730 2020 [PMID: 33391255]
  177. Galson JD, Schaetzle S, Bashford-Rogers RJM, Raybould MIJ, Kovaltsuk A, Kilpatrick GJ, Minter R, Finch DK, Dias J, James LK, Thomas G, Lee WJ, Betley J, Cavlan O, Leech A, Deane CM, Seoane J, Caldas C, Pennington DJ, Pfeffer P, Osbourn J. Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures Frontiers in immunology 11:605170 2020 [PMID: 33384691]
  178. Peng X, Ouyang J, Isnard S, Lin J, Fombuena B, Zhu B, Routy JP. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System Frontiers in immunology 11:596631 2020 [PMID: 33384690]
  179. Andrade BS, Rangel FS, Santos NO, Freitas ADS, Soares WRA, Siqueira S, Barh D, Góes-Neto A, Birbrair A, Azevedo VAC. Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review Frontiers in pharmacology 11:590598 2020 [PMID: 33390967]
  180. Lico C, Santi L, Baschieri S, Noris E, Marusic C, Donini M, Pedrazzini E, Maga G, Franconi R, Di Bonito P, Avesani L. Plant Molecular Farming as a Strategy Against COVID-19 - The Italian Perspective Frontiers in plant science 11:609910 2020 [PMID: 33381140]
  181. Kurtovic L, Beeson JG. Complement Factors in COVID-19 Therapeutics and Vaccines Trends in immunology 2020 [PMID: 33402318]
  182. El-Betany AMM, Behiry EM, Gumbleton M, Harding KG. Humidified Warmed CO<sub>2</sub> Treatment Therapy Strategies Can Save Lives With Mitigation and Suppression of SARS-CoV-2 Infection: An Evidence Review Frontiers in medicine 7:594295 2020 [PMID: 33425942]
  183. Diniz TA, Christofaro DGD, Tebar WR, Cucato GG, Botero JP, Correia MA, Ritti-Dias RM, Lofrano-Prado MC, Prado WL. Reduction of Physical Activity Levels During the COVID-19 Pandemic Might Negatively Disturb Sleep Pattern Frontiers in psychology 11:586157 2020 [PMID: 33424702]
  184. Gheorghe AS, Negru ŞM, Nițipir C, Mazilu L, Marinca M, Gafton B, Ciuleanu TE, Schenker M, Dragomir RD, Gheorghe AD, Stovicek PO, Bandi-Vasilica M, Boț AC, Mihăilă RI, Zob DL, Kajanto AL, Stănculeanu DL. Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey ESMO open 6(1):100027 2020 [PMID: 33399089]
  185. Tapela K, Ochieng' Olwal C, Quaye O. Parallels in the pathogenesis of SARS-CoV-2 and <i>M. tuberculosis</i>: a synergistic or antagonistic alliance? Future microbiology 15:1691-1695 2020 [PMID: 33404259]
  186. Ray M, Sarkar S, Rath SN. Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2 Genomics & informatics 18(4):e43 2020 [PMID: 33412759]
  187. Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, Dhama K, Harapan H. SARS-CoV-2 reinfection and implications for vaccine development Human vaccines & immunotherapeutics 16(12):3061-3073 2020 [PMID: 33393854]
  188. Dhama K, Singh Malik Y, Rabaan AA, Rodriguez-Morales AJ. Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics' Human vaccines & immunotherapeutics 16(12):2888-2890 2020 [PMID: 33393853]
  189. Freckelton I. The Rights to Life, Dignity and the Highest Attainable Standard of Health: Internationally Influential African Jurisprudence Journal of law and medicine 28(1):9-20 2020 [PMID: 33415887]
  190. Breitbart W. Trust in the age of COVID-19 Palliative & supportive care 18(6):634-635 2020 [PMID: 33399037]
  191. Yıldız Gülhan P. The role of mesenchymal stem cells in COVID-19 treatment Tuberkuloz ve toraks 68(4):430-436 2020 [PMID: 33448740]
  192. Ratha SK, Renuka N, Rawat I, Bux F. Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases Nutrition (Burbank, Los Angeles County, Calif.) 83:111089 2020 [PMID: 33412367]
  193. Gundlapalli AV, Salerno RM, Brooks JT, Averhoff F, Petersen LR, McDonald LC, Iademarco MF. SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response Open forum infectious diseases 8(1):ofaa555 2021 [PMID: 33442555]
  194. Kim SH, Jang YS. Recent Insights into Cellular Crosstalk in Respiratory and Gastrointestinal Mucosal Immune Systems Immune network 20(6):e44 2020 [PMID: 33425429]
  195. Soremekun OS, Omolabi KF, Adewumi AT, Soliman ME. Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective Future science OA 7(1):FSO640 2020 [PMID: 33432269]
  196. MacDonald NE. Fake news and science denier attacks on vaccines. What can you do? Canada communicable disease report = Releve des maladies transmissibles au Canada 46(1112):432-435 2020 [PMID: 33447164]
  197. Dayneka N, Jensen C, Hildebrand K. Canadian Immunization Guide: "Anaphylaxis and other acute reactions following vaccination" chapter update Canada communicable disease report = Releve des maladies transmissibles au Canada 46(1112):384-386 2020 [PMID: 33447159]
  198. . Antiviral drugs for influenza for 2020-2021 The Medical letter on drugs and therapeutics 62(1610):169-172 2020 [PMID: 33429402]
  199. Schwarz Chavarri G, Sánchez Hernández C, Moreno Millán N, Morató Agustí ML, Martín Martín S, Javierre Miranda AP, Gutierrez Pérez MI, Gómez Marco JJ, García Iglesias C, Aldaz Herce P. [Infectious Disease Prevention Group. Update on vaccines, 2020] Atencion primaria 52 Suppl 2:70-92 2020 [PMID: 33388119]
  200. Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine : international journal of phytotherapy and phytopharmacology :153396 2020 [PMID: 33380375]
  201. Hejaz HA. Palestinian strategies, guidelines, and challenges in the treatment and management of coronavirus disease-2019 (COVID-19) Avicenna journal of medicine 10(4):135-162 2020 [PMID: 33437687]
  202. Sanicas M, Sanicas M, Diop D, Montomoli E. A review of COVID-19 vaccines in development: 6 months into the pandemic The Pan African medical journal 37:124 2020 [PMID: 33425157]
  203. Eftekhar SP, Kazemi S, Moghadamnia AA. A brief review of the latest pharmacological treatments of COVID-19 Caspian journal of internal medicine 11(Suppl 1):460-465 2020 [PMID: 33425262]
  204. Molaei S, Dadkhah M, Asghariazar V, Karami C, Safarzadeh E. The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies International immunopharmacology 92:107051 2020 [PMID: 33429331]
  205. Akyala AI, Muhammad L, Akabe E, Akinyoade A, Agogo E. Person to person transmission of pneumonia associated with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a familial cluster analysis in North Central Nigeria The Pan African medical journal 37:99 2020 [PMID: 33425132]
  206. Makhoul AT, Drolet BC. A Reserve System for the Equitable Allocation of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Chest 2020 [PMID: 33453180]
  207. Cunha TCA, Rossi R, Marson LCG, Guimaraes TM, Machado MAC, Meira-E-Cruz M, Ferraz O, Maluly Filho M, Cunali PA, Chaves Júnior CM, Dal-Fabbro C. COVID-19 and dental sleep medicine: risks, precautions and patient guidance Sleep science (Sao Paulo, Brazil) 13(3):195-198 2020 [PMID: 33381287]
  208. Mazumdar P, Kaushik M, Chandrasekhar V, Mohan Kumar RS, Rajawat A. Position Statement of IACDE for managing dental patients during COVID-19 Journal of conservative dentistry : JCD 23(2):114-120 2020 [PMID: 33384480]
  209. Veljkovic V, Vergara-Alert J, Segalés J, Paessler S. Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target F1000Research 9:52 2020 [PMID: 32419926]
  210. Atehortua NA, Patino S. COVID-19, a tale of two pandemics: novel coronavirus and fake news messaging Health promotion international 2020 [PMID: 33450022]
  211. Smetanová J, Střížová Z, Bartůňková J, Milota T. Principles and new perspectives in the vaccination against SARS-CoV-2 virus Casopis lekaru ceskych 159(7-8):298-302 2020 [PMID: 33445936]
  212. Sreepadmanabh M, Sahu AK, Chande A. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development Journal of biosciences 45 2020 [PMID: 33410425]
  213. Braithwaite R, Warren R. The African American Petri Dish Journal of health care for the poor and underserved 31(2):491-502 2020 [PMID: 33410785]

Coxiella burnetii (Q fever)

  1. Sarangi LN, Tharani N, Polapally S, Rana SK, Thodangala N, Bahekar VS, Prasad A, Chandrasekhar Reddy RV, Surendra KSNL, Gonuguntla HN, Ponnanna NM, Sharma GK. Infectious bovine abortions: observations from an organized dairy herd Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2021 [PMID: 33415719]

Cryptosporidium parvum

  1. Kurenzvi L, Sebunya TK, Coetzee T, Paganotti GM, Teye MV. Prevalence of <i>Cryptosporidium parvum, Giardia intestinali</i>s and molecular characterization of group A rotavirus associated with diarrhea in children below five years old in Gaborone, Botswana The Pan African medical journal 37:159 2020 [PMID: 33425192]

Ebola virus

  1. Kurup D, Fisher CR, Scher G, Yankowski C, Testa A, Keshwara R, Abreu-Mota T, Lambert R, Ferguson M, Rinaldi W, Ruiz L, Wirblich C, Schnell MJ. Tetravalent rabies-vectored Filovirus and Lassa fever vaccine induces long-term immunity in nonhuman primates The Journal of infectious diseases 2021 [PMID: 33421072]
  2. Choi MJ, Cossaboom CM, Whitesell AN, Dyal JW, Joyce A, Morgan RL, Campos-Outcalt D, Person M, Ervin E, Yu YC, Rollin PE, Harcourt BH, Atmar RL, Bell BP, Helfand R, Damon IK, Frey SE. Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020 MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 70(1):1-12 2021 [PMID: 33417593]
  3. Lingas G, Rosenke K, Safronetz D, Guedj J. Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin PLoS computational biology 17(1):e1008535 2021 [PMID: 33411731]
  4. Pinski A, Woolsey C, Jankeel A, Cross R, Basler CF, Geisbert T, Messaoudi I. Transcriptional analysis of lymphoid tissues from infected nonhuman primates reveals the basis for attenuation and immunogenicity of an Ebola virus encoding a mutant VP35 protein Journal of virology 2021 [PMID: 33408171]
  5. Midha IK, Kumar N, Kumar A, Madan T. Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings Reviews in medical virology :e2204 2020 [PMID: 33382930]
  6. Bennett RP, Finch CL, Postnikova EN, Stewart RA, Cai Y, Yu S, Liang J, Dyall J, Salter JD, Smith HC, Kuhn JH. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures Viruses 13(1) 2020 [PMID: 33396288]
  7. Appiah-Sakyi K, Mohan M, Konje JC. Ebola infection in pregnancy, an ongoing challenge for both the global health expert and the pregnant woman-A review European journal of obstetrics, gynecology, and reproductive biology 258:111-117 2020 [PMID: 33421807]
  8. Mensah EA, Kisakye A, Gyasi SO. Ebola virus disease surveillance in the absence of a confirmed case; the case of the Rwenzori region of Uganda The Pan African medical journal 37:137 2020 [PMID: 33425170]
  9. Furuyama W, Reynolds P, Haddock E, Meade-White K, Quynh Le M, Kawaoka Y, Feldmann H, Marzi A. A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades NPJ vaccines 5(1):4 2020 [PMID: 33420066]

Escherichia coli

  1. Jiang X, Bai J, Yuan J, Zhang H, Lu G, Wang Y, Jiang L, Liu B, Wang L, Huang D, Feng L. High efficiency biosynthesis of O-polysaccharide-based vaccines against extraintestinal pathogenic Escherichia coli Carbohydrate polymers 255:117475 2021 [PMID: 33436239]
  2. de Alwis R, Liang L, Taghavian O, Werner E, The HC, Thu TNH, Duong VT, Davies DH, Felgner PL, Baker S. The identification of novel immunogenic antigens as potential Shigella vaccine components Genome medicine 13(1):8 2021 [PMID: 33451348]
  3. Lyons BJE, Atkinson CE, Deng W, Serapio-Palacios A, Finlay BB, Strynadka NCJ. Cryo-EM structure of the EspA filament from enteropathogenic Escherichia coli: revealing the mechanism of effector translocation in the T3SS Structure (London, England : 1993) 2021 [PMID: 33453150]
  4. Gozdziewicz TK, Maciejewska A, Tsybulska A, Lugowski C, Lukasiewicz J. A New Look at the Enterobacterial Common Antigen Forms Obtained during Rough Lipopolysaccharides Purification International journal of molecular sciences 22(2) 2021 [PMID: 33445776]
  5. Begier E, Rosenthal NA, Gurtman A, Kartashov A, Donald RGK, Lockhart SP. Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status among Patients Treated in U.S. Hospitals: 2009-2016 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 [PMID: 33420788]
  6. Yadav SK, Dash P, Sahoo PK, Garg LC, Dixit A. Recombinant outer membrane protein OmpC induces protective immunity against Aeromonashydrophila infection in Labeorohita Microbial pathogenesis 150:104727 2021 [PMID: 33429054]
  7. Alber A, Stevens MP, Vervelde L. The bird's immune response to avian pathogenic <i>Escherichia coli</i> Avian pathology : journal of the W.V.P.A :1-23 2021 [PMID: 33410704]
  8. Lipworth S, Vihta KD, Chau KK, Kavanagh J, Davies T, George S, Barker L, Vaughan A, Andersson M, Jeffery K, Oakley S, Morgan M, Peto TEA, Crook DW, Walker AS, Stoesser N. Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 [PMID: 33411882]
  9. Jiang S, Noh J, Park C, Smith AD, Abbott NL, Zavala VM. Using machine learning and liquid crystal droplets to identify and quantify endotoxins from different bacterial species The Analyst 2021 [PMID: 33393547]
  10. Teh AY, Cavacini L, Hu Y, Kumru OS, Xiong J, Bolick DT, Joshi SB, Grünwald-Gruber C, Altmann F, Klempner M, Guerrant RL, Volkin DB, Wang Y, Ma JK. Investigation of a monoclonal antibody against enterotoxigenic <i>Escherichia coli</i>, expressed as secretory IgA1 and IgA2 in plants Gut microbes 13(1):1-14 2021 [PMID: 33439092]
  11. Wang J, Liu Y, Chen Y, Zhang T, Wang A, Wei Q, Liu D, Wang F, Zhang G. Capsid assembly is regulated by amino acid residues asparagine 47 and 48 in the VP2 protein of porcine parvovirus Veterinary microbiology 253:108974 2020 [PMID: 33433338]

Francisella tularensis (Tularemia)

  1. Golovliov I, Bäckman S, Granberg M, Salomonsson E, Lundmark E, Näslund J, Busch JD, Birdsell D, Sahl JW, Wagner DM, Johansson A, Forsman M, Thelaus J. Long-term survival of virulent tularemia pathogens outside a host in conditions that mimic natural aquatic environments Applied and environmental microbiology 2021 [PMID: 33397692]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Montefiori DC, Filsinger Interrante MV, Bell BN, Rubio AA, Joyce JG, Shiver JW, LaBranche CC, Kim PS. The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat Proceedings of the National Academy of Sciences of the United States of America 118(3) 2021 [PMID: 33431684]
  2. Rezaie J, Aslan C, Ahmadi M, Zolbanin NM, Kashanchi F, Jafari R. The versatile role of exosomes in human retroviral infections: from immunopathogenesis to clinical application Cell & bioscience 11(1):19 2021 [PMID: 33451365]
  3. Hie B, Zhong ED, Berger B, Bryson B. Learning the language of viral evolution and escape Science (New York, N.Y.) 371(6526):284-288 2021 [PMID: 33446556]
  4. Feder AF, Pennings PS, Petrov DA. The clarifying role of time series data in the population genetics of HIV PLoS genetics 17(1):e1009050 2021 [PMID: 33444376]
  5. Dingens AS, Pratap P, Malone KD, Hilton SK, Ketas T, Cottrell CA, Overbaugh JM, Moore JP, Klasse PJ, Ward AB, Bloom JD. High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post HIV Env trimer vaccination eLife 10 2021 [PMID: 33438580]
  6. Matsuoka S, Kuwata T, Ishii H, Sekizuka T, Kuroda M, Sano M, Okazaki M, Yamamoto H, Shimizu M, Matsushita S, Seki Y, Saito A, Sakawaki H, Hirsch VM, Miura T, Akari H, Matano T. A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques Journal of virology 2021 [PMID: 33441342]
  7. Sangare K, Tuero I, Rahman MA, Hoang T, Miller-Novak LK, Vargas-Inchaustegui DA, Venzon DJ, LaBranche C, Montefiori DC, Robert-Guroff M, Thomas MA. The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates Journal of virology 2021 [PMID: 33441339]
  8. Gondim MVP, Sherrill-Mix S, Bibollet-Ruche F, Russell RM, Trimboli S, Smith AG, Li Y, Liu W, Avitto AN, DeVoto JC, Connell J, Fenton-May AE, Pellegrino P, Williams I, Papasavvas E, Lorenzi JCC, Salantes DB, Mampe F, Monroy MA, Cohen YZ, Heath S, Saag MS, Montaner LJ, Collman RG, Siliciano JM, Siliciano RF, Plenderleith LJ, Sharp PM, Caskey M, Nussenzweig MC, Shaw GM, Borrow P, Bar KJ, Hahn BH. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption Science translational medicine 13(576) 2021 [PMID: 33441429]
  9. Singh V, Dashti A, Mavigner M, Chahroudi A. Latency Reversal 2.0: Giving the Immune System a Seat at the Table Current HIV/AIDS reports 2021 [PMID: 33433817]
  10. Garcia-Bates TM, Palma ML, Anderko RR, Hsu DC, Ananworanich J, Korber BT, Gaiha GD, Phanuphak N, Thomas R, Tovanabutra S, Walker BD, Mellors JW, Piazza PA, Kroon E, Riddler SA, Michael NL, Rinaldo CR, Mailliard RB. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes EBioMedicine 63:103175 2021 [PMID: 33450518]
  11. Cardozo-Ojeda EF, Duke ER, Peterson CW, Reeves DB, Mayer BT, Kiem HP, Schiffer JT. Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation eLife 10 2021 [PMID: 33432929]
  12. Akmatov MK, Holstiege J, Steffen A, Bätzing J. Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis Vaccine 2021 [PMID: 33451775]
  13. Doepker LE, Danon S, Harkins E, Ralph DK, Yaffe Z, Garrett ME, Dhar A, Wagner C, Stumpf MM, Arenz D, Williams JA, Jaoko W, Mandaliya K, Lee KK, Matsen FA 4th, Overbaugh JM. Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies eLife 10 2021 [PMID: 33427196]
  14. Kannigadu C, N'Da DD. Recent Advances in the Synthesis and Development of Curcumin, its Combinations, Formulations and Curcumin-like Compounds as Antiinfective Agents Current medicinal chemistry 2021 [PMID: 33430722]
  15. Palumbo PJ, Zhang Y, Clarke W, Breaud A, Sivay M, Cummings V, Hamilton EL, Guo X, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort TGM, Eshleman SH. Uptake of antiretroviral treatment and viral suppression among men who have sex with men and transgender women in sub-Saharan Africa in an observational cohort study: HPTN 075 International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021 [PMID: 33440260]
  16. Lopez-Santamarina A, Lamas A, Del Carmen Mondragón A, Cardelle-Cobas A, Regal P, Rodriguez-Avila JA, Miranda JM, Franco CM, Cepeda A. Probiotic Effects against Virus Infections: New Weapons for an Old War Foods (Basel, Switzerland) 10(1) 2021 [PMID: 33435315]
  17. Luque FJ, Camarasa MJ. HIV-1 Envelope Spike MPER: From a Vaccine Target to a New Druggable Pocket for Novel and Effective Fusion Inhibitors ChemMedChem 16(1):105-107 2021 [PMID: 33428329]
  18. Shabani SH, Kardani K, Milani A, Bolhassani A. <i>In Silico</i> and <i>in Vivo</i> Analysis of HIV-1 Rev Regulatory Protein for Evaluation of a Multiepitope-based Vaccine Candidate Immunological investigations :1-28 2021 [PMID: 33416004]
  19. Nunes MC, Cutland CL, Klugman KP, Madhi SA. Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV mBio 12(1) 2021 [PMID: 33419872]
  20. Prasoppokakorn T, Vanichanan J, Chaiteerakij R, Jutivorakool K, Udomkarnjananun S, Pongpirul K, Taesombat W, Wattanatorn S, Avihingsanon Y, Tungsanga K, Eiam-Ong S, Praditpornsilpa K, Townamchai N. A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients Scientific reports 11(1):50 2021 [PMID: 33420114]
  21. Nyombayire J, Ingabire R, Mukamuyango J, Mazzei A, Wall KM, Karita E, Parker R, Tichacek A, Hunter E, Price MA, Allen S. ART use and HIV transmission among discordant couples in non-research settings in Kigali, Rwanda Sexually transmitted diseases Publish Ahead of Print 2021 [PMID: 33433171]
  22. Chen X, Zhou T, Schmidt SD, Duan H, Cheng C, Chuang GY, Gu Y, Louder MK, Lin BC, Shen CH, Sheng Z, Zheng MX, Doria-Rose NA, Joyce MG, Shapiro L, Tian M, Alt FW, Kwong PD, Mascola JR. Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with &gt;50% breadth Immunity 2021 [PMID: 33453152]
  23. Goh GK, Uversky VN. Shell disorder and the HIV vaccine mystery: lessons from the legendary Oswald Avery Journal of biomolecular structure & dynamics :1-10 2021 [PMID: 33410379]
  24. Alamer E, Zhong C, Hajnik R, Soong L, Hu H. Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure Retrovirology 18(1):3 2021 [PMID: 33413475]
  25. Caldera F, Mercer M, Samson SI, Pitt JM, Hayney MS. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity Vaccine 2021 [PMID: 33422377]
  26. Chissaque A, Cassocera M, Gasparinho C, Langa JS, Bauhofer AFL, Chilaúle JJ, João ED, Munlela BA, Sambo JAM, Boene SS, Djedje MB, Anapakala EM, Guimarães EL, Bero DM, Manhique-Coutinho LV, Cossa-Moiane I, Kellogg TA, Gonçalves LAP, de Deus N. Rotavirus A infection in children under five years old with a double health problem: undernutrition and diarrhoea - a cross-sectional study in four provinces of Mozambique BMC infectious diseases 21(1):18 2021 [PMID: 33407207]
  27. Salyani A, Shah J, Adam R, Otieno G, Mbugua E, Shah R. Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults PloS one 16(1):e0244947 2021 [PMID: 33406137]
  28. Price NB, Grose C. Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination Vaccines 9(1) 2021 [PMID: 33418856]
  29. Triant VA, Gandhi RT. When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 [PMID: 33395474]
  30. Boey L, Bosmans E, Ferreira LB, Heyvaert N, Nelen M, Smans L, Tuerlinckx H, Roelants M, Claes K, Derdelinckx I, Janssens W, Mathieu C, Van Cleemput J, Vos R, Desombere I, Vandermeulen C. Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients Vaccines 9(1) 2021 [PMID: 33406698]
  31. Barik SK, Bansal AK, Mohanty PS, Tripathy SP, Hanna LE, Ramesh K, Sathyamoorthy P, Singh TP, Tandon R, Tomar S, Jena S, Patil SA, Mohanty KK. Detection of drug resistance mutations in the reverse transcriptase gene of HIV-1-infected North Indian population failing first line antiretroviral therapy "A follow-up cohort study" AIDS research and human retroviruses 2021 [PMID: 33390085]
  32. Jain P, Dewan P, Gomber S, Kashyap B, Raizada A. Three vs Four Dose Schedule of Double Strength Recombinant Hepatitis-B Vaccine in HIV-infected Children: A Randomized Controlled Trial Indian pediatrics 2021 [PMID: 33408274]
  33. Philbin MM, Parish C, Bergen S, Kerrigan D, Kinnard EN, Reed SE, Cohen MH, Sosanya O, Sheth AN, Adimora AA, Cocohoba J, Goparaju L, Golub ET, Fischl M, Alcaide ML, Metsch LR. A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use AIDS patient care and STDs 35(1):23-30 2021 [PMID: 33400587]
  34. Davoodi S, Bolhassani A, Namazi F. In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate Biotechnology letters 2021 [PMID: 33386500]
  35. Iliyasu Z, Hassan-Hanga F, Ajuji SI, Bello MM, Abdulkadir SS, Nass NS, Salihu HM, Aliyu MH. Correlates of Health Care Workers' Knowledge and HIV-Exposed Infant Immunization Counseling Practice in Northern Nigeria International journal of MCH and AIDS 10(1):55-65 2021 [PMID: 33442492]
  36. Saunders KO, Pardi N, Parks R, Santra S, Mu Z, Sutherland L, Scearce R, Barr M, Eaton A, Hernandez G, Goodman D, Hogan MJ, Tombacz I, Gordon DN, Rountree RW, Wang Y, Lewis MG, Pierson TC, Barbosa C, Tam Y, Shen X, Ferrari G, Tomaras GD, Montefiori DC, Weissman D, Haynes BF. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates bioRxiv : the preprint server for biology 2020 [PMID: 33398289]
  37. Larijani MS, Sadat SM, Bolhassani A, Khodaie A, Pouriayevali MH, Ramezani A. HIV-1 p24-nef DNA Vaccine plus Protein Boost Expands T-Cell Responses in BALB/c Current drug delivery 2020 [PMID: 33388019]
  38. Tola HH, Gamtesa DF. High Inequality and Slow Services Improvement in Newborn and Child Health Interventions in Ethiopia Pediatric health, medicine and therapeutics 11:513-523 2020 [PMID: 33408550]
  39. Milani A, Baesi K, Agi E, Marouf G, Ahmadi M, Bolhassani A. HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development? Protein and peptide letters 2020 [PMID: 33390106]
  40. Vernazza PL, Rasi M, Ritzler M, Dost F, Stoffel M, Aebi-Popp K, Hauser CV, Esson C, Lange K, Risch L, Schmidt AJ. The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women Swiss medical weekly 150:w20393 2020 [PMID: 33382076]
  41. Nifant'ev I, Siniavin A, Karamov E, Kosarev M, Kovalchuk S, Turgiev A, Nametkin S, Bagrov V, Tavtorkin A, Ivchenko P. A New Approach to Developing Long-Acting Injectable Formulations of Anti-HIV Drugs: Poly(Ethylene Phosphoric Acid) Block Copolymers Increase the Efficiency of Tenofovir against HIV-1 in MT-4 Cells International journal of molecular sciences 22(1) 2020 [PMID: 33396968]
  42. Anjorin AA, Adepoju BA. Serologic evidence of seasonal influenza A and B in HIV patients on combined antiretroviral therapy in Lagos, Nigeria African journal of laboratory medicine 9(1):1048 2020 [PMID: 33392051]
  43. Peng X, Ouyang J, Isnard S, Lin J, Fombuena B, Zhu B, Routy JP. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System Frontiers in immunology 11:596631 2020 [PMID: 33384690]
  44. Singh T, Otero CE, Li K, Valencia SM, Nelson AN, Permar SR. Vaccines for Perinatal and Congenital Infections-How Close Are We? Frontiers in pediatrics 8:569 2020 [PMID: 33384972]
  45. Bastida I, Fernández-Tejada A. Synthetic carbohydrate-based HIV-1 vaccines Drug discovery today. Technologies 35-36:45-56 2020 [PMID: 33388127]
  46. Donà MG, Rollo F, Latini A, Benevolo M, Pichi B, Pellini R, Giuliani E, Giglio A, Cristaudo A, Giuliani M. Anal and oral human papillomavirus infection in men who have sex with men: implications for risk-targeted vaccination Future microbiology 15:1713-1722 2020 [PMID: 33404267]
  47. Freckelton I. The Rights to Life, Dignity and the Highest Attainable Standard of Health: Internationally Influential African Jurisprudence Journal of law and medicine 28(1):9-20 2020 [PMID: 33415887]
  48. de Vries-Sluijs TEMS, Andrinopoulou ER, de Man RA, van der Ende ME. Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination schedule The Netherlands journal of medicine 78(6):376-380 2020 [PMID: 33380535]
  49. Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS, MacNeil JR. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020 MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 69(9):1-41 2020 [PMID: 33417592]
  50. Ramaswamy M, Bruden D, Nolen LD, Mosites E, Snowball M, Nelson NP, Bruce M, McMahon BJ. Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska Journal of medical virology 2020 [PMID: 33448443]

Lassa virus

  1. Kurup D, Fisher CR, Scher G, Yankowski C, Testa A, Keshwara R, Abreu-Mota T, Lambert R, Ferguson M, Rinaldi W, Ruiz L, Wirblich C, Schnell MJ. Tetravalent rabies-vectored Filovirus and Lassa fever vaccine induces long-term immunity in nonhuman primates The Journal of infectious diseases 2021 [PMID: 33421072]
  2. Lingas G, Rosenke K, Safronetz D, Guedj J. Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin PLoS computational biology 17(1):e1008535 2021 [PMID: 33411731]

Marburg virus

  1. Kurup D, Fisher CR, Scher G, Yankowski C, Testa A, Keshwara R, Abreu-Mota T, Lambert R, Ferguson M, Rinaldi W, Ruiz L, Wirblich C, Schnell MJ. Tetravalent rabies-vectored Filovirus and Lassa fever vaccine induces long-term immunity in nonhuman primates The Journal of infectious diseases 2021 [PMID: 33421072]
  2. Müller C, Obermann W, Karl N, Wendel HG, Taroncher-Oldenburg G, Pleschka S, Hartmann RK, Grünweller A, Ziebuhr J. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo Antiviral research 186:105012 2021 [PMID: 33422611]
  3. Bennett RP, Finch CL, Postnikova EN, Stewart RA, Cai Y, Yu S, Liang J, Dyall J, Salter JD, Smith HC, Kuhn JH. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures Viruses 13(1) 2020 [PMID: 33396288]

Mycobacterium tuberculosis (tuberculosis)

  1. Rezaie J, Aslan C, Ahmadi M, Zolbanin NM, Kashanchi F, Jafari R. The versatile role of exosomes in human retroviral infections: from immunopathogenesis to clinical application Cell & bioscience 11(1):19 2021 [PMID: 33451365]
  2. Kauffman KD, Sakai S, Lora NE, Namasivayam S, Baker PJ, Kamenyeva O, Foreman TW, Nelson CE, Oliveira-de-Souza D, Vinhaes CL, Yaniv Z, Lindestam Arleham CS, Sette A, Freeman GJ, Moore R, Sher A, Mayer-Barber KD, Andrade BB, Kabat J, Via LE, Barber DL. PD-1 blockade exacerbates <i>Mycobacterium tuberculosis</i> infection in rhesus macaques Science immunology 6(55) 2021 [PMID: 33452107]
  3. Kumar S, Bhaskar A, Patnaik G, Sharma C, Singh DK, Kaushik S, Chaturvedi S, Das G, Dwivedi VP. Intranasal Immunization with Peptide-based Immunogenic Complex Enhances BCG Vaccine Efficacy in murine model of Tuberculosis JCI insight 2021 [PMID: 33444288]
  4. Bibi S, Ullah I, Zhu B, Adnan M, Liaqat R, Kong WB, Niu S. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology Scientific reports 11(1):1249 2021 [PMID: 33441913]
  5. Hadi SA, Kolte IV, Brenner EP, Cunha EAT, Simonsen V, Ferrazoli L, Villela DAM, Santos RS, Ravi J, Sreevatsan S, Basta PC. Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous population Scientific reports 11(1):1224 2021 [PMID: 33441660]
  6. Potter EL, Gideon HP, Tkachev V, Fabozzi G, Chassiakos A, Petrovas C, Darrah PA, Lin PL, Foulds KE, Kean LS, Flynn JL, Roederer M. Measurement of leukocyte trafficking kinetics in macaques by serial intravascular staining Science translational medicine 13(576) 2021 [PMID: 33441427]
  7. Shaibu JO, Onwuamah CK, James AB, Okwuraiwe AP, Amoo OS, Salu OB, Ige FA, Liboro G, Odewale E, Okoli LC, Ahmed RA, Achanya D, Adesesan A, Amuda OA, Sokei J, Oyefolu BAO, Salako BL, Omilabu SA, Audu RA. Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria PloS one 16(1):e0243271 2021 [PMID: 33428634]
  8. Kannigadu C, N'Da DD. Recent Advances in the Synthesis and Development of Curcumin, its Combinations, Formulations and Curcumin-like Compounds as Antiinfective Agents Current medicinal chemistry 2021 [PMID: 33430722]
  9. Aggio JB, Krmeská V, Ferguson BJ, Wowk PF, Rothfuchs AG. Vaccinia Virus Infection Inhibits Skin Dendritic Cell Migration to the Draining Lymph Node Journal of immunology (Baltimore, Md. : 1950) 2021 [PMID: 33419767]
  10. Crevel RV, Critchley JA. The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice Tropical medicine and infectious disease 6(1) 2021 [PMID: 33435609]
  11. Ryter KT, Rasheed OK, Buhl C, Evans JT. Design of Trehalose-based Amide/Sulfonamide C-type Lectin Receptor Ligands ChemMedChem 2021 [PMID: 33415819]
  12. Mustafa AS. Immunological Characterization of Proteins Expressed by Genes Located in <i>Mycobacterium tuberculosis</i>-Specific Genomic Regions Encoding the ESAT6-like Proteins Vaccines 9(1) 2021 [PMID: 33430286]
  13. Mpande CAM, Musvosvi M, Rozot V, Mosito B, Reid TD, Schreuder C, Lloyd T, Bilek N, Huang H, Obermoser G, Davis MM, Ruhwald M, Hatherill M, Scriba TJ, Nemes E. Antigen-specific T Cell Activation Distinguishes Between Recent and Remote Tuberculosis Infection American journal of respiratory and critical care medicine 2021 [PMID: 33406011]
  14. Togun T. Childhood tuberculosis in high burden settings EBioMedicine 63:103181 2021 [PMID: 33421948]
  15. Hadifar S, Fateh A, Pourbarkhordar V, Siadat SD, Mostafaei S, Vaziri F. Variation in Mycobacterium tuberculosis population structure in Iran: a systemic review and meta-analysis BMC infectious diseases 21(1):2 2021 [PMID: 33397308]
  16. Biadglegne F, König B, Rodloff AC, Dorhoi A, Sack U. Composition and Clinical Significance of Exosomes in Tuberculosis: A Systematic Literature Review Journal of clinical medicine 10(1) 2021 [PMID: 33406750]
  17. White AD, Sibley L, Sarfas C, Morrison A, Gullick J, Clark S, Gleeson F, McIntyre A, Arlehamn CL, Sette A, Salguero FJ, Rayner E, Rodriguez E, Puentes E, Laddy D, Williams A, Dennis M, Martin C, Sharpe S. MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies NPJ vaccines 6(1):4 2021 [PMID: 33397991]
  18. Tanner R, White AD, Boot C, Sombroek CC, O'Shea MK, Wright D, Hoogkamer E, Bitencourt J, Harris SA, Sarfas C, Wittenberg R, Satti I, Fletcher HA, Verreck FAW, Sharpe SA, McShane H. A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates NPJ vaccines 6(1):3 2021 [PMID: 33397986]
  19. Ito T, Sugiura K, Hasegawa A, Ouchi W, Yoshimoto T, Mizoguchi I, Inaba T, Hamada K, Eriguchi M, Koyama Y. Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells Pharmaceutics 13(1) 2021 [PMID: 33406722]
  20. Ramharter M, Agnandji ST, Adegnika AA, Lell B, Mombo-Ngoma G, Grobusch MP, McCall M, Muranaka R, Kreidenweiss A, Velavan TP, Esen M, Schaumburg F, Alabi A, Druml C, Mordmüller B, Köhler C, Kremsner PG. Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon Wiener klinische Wochenschrift 2021 [PMID: 33398458]
  21. Barik SK, Bansal AK, Mohanty PS, Tripathy SP, Hanna LE, Ramesh K, Sathyamoorthy P, Singh TP, Tandon R, Tomar S, Jena S, Patil SA, Mohanty KK. Detection of drug resistance mutations in the reverse transcriptase gene of HIV-1-infected North Indian population failing first line antiretroviral therapy "A follow-up cohort study" AIDS research and human retroviruses 2021 [PMID: 33390085]
  22. Mosavari N, Karimi A, Tadayon K, Shahhosseini G, Zavaran Hosseini A, Babaie M. Evaluation of Heating and Irradiation Methods for Production of Purified Protein Derivative (PPD) of Mycobacterium Tuberculosis Archives of Razi Institute 75(4):439-449 2021 [PMID: 33403839]
  23. Khan MSA, Nain Z, Syed SB, Abdulla F, Moni MA, Sheam MM, Karim MM, Adhikari UK. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus Molecular and cellular probes 55:101693 2020 [PMID: 33388416]
  24. Jagadeb M, Pattanaik KP, Rath SN, Sonawane A. Identification and evaluation of immunogenic MHC-I and MHC-II binding peptides from Mycobacterium tuberculosis Computers in biology and medicine 130:104203 2020 [PMID: 33450502]
  25. Moulson AJ, Av-Gay Y. BCG immunomodulation: From the 'hygiene hypothesis' to COVID-19 Immunobiology 226(1):152052 2020 [PMID: 33418320]
  26. Gutema FD, Agga GE, Makita K, Smith RL, Mourits M, Tufa TB, Leta S, Beyene TJ, Asefa Z, Urge B, Ameni G. Evaluation of the Control Options of Bovine Tuberculosis in Ethiopia Using a Multi-Criteria Decision Analysis Frontiers in veterinary science 7:586056 2020 [PMID: 33392283]
  27. Martínez-Santana V, Fernández-Cañabate S, Fernández-Cañabate E, Boix-Montañés A, Miserachs-Aranda N, Modamio-Charles P. Biologic therapies committee. What does it provide? Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 45(1):10-15 2020 [PMID: 33443472]
  28. Tapela K, Ochieng' Olwal C, Quaye O. Parallels in the pathogenesis of SARS-CoV-2 and <i>M. tuberculosis</i>: a synergistic or antagonistic alliance? Future microbiology 15:1691-1695 2020 [PMID: 33404259]
  29. Mobed A. DNA Based Vaccines against Mycobacterium Tuberculosis: Recent Progress in Vaccine Development and Delivery System Iranian journal of immunology : IJI 17(4):255-274 2020 [PMID: 33382383]
  30. Martínez L, Vázquez S, Flores MLM, Notejane M, Zabala C, Giachetto G, Sisto G, Barrios P. [Extrapulmonary tuberculosis in children under the age of 15 hospitalized at the Pereira Rossell Hospital Center, Uruguay] Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 37(5):577-583 2020 [PMID: 33399807]
  31. Yamoah P, Bangalee V, Oosthuizen F. A review of the safety of vaccines used in routine immunization in Africa African health sciences 20(1):227-237 2020 [PMID: 33402911]
  32. Bettencourt P, Müller J, Nicastri A, Cantillon D, Madhavan M, Charles PD, Fotso CB, Wittenberg R, Bull N, Pinpathomrat N, Waddell SJ, Stylianou E, Hill AVS, Ternette N, McShane H. Identification of antigens presented by MHC for vaccines against tuberculosis NPJ vaccines 5(1):2 2020 [PMID: 33386393]
  33. Thomas G. Keeping Vaccination Simple: Building French Immunization Schedules, 1959-1999 Bulletin of the history of medicine 94(3):423-458 2020 [PMID: 33416725]

Plasmodium falciparum (Malaria)

  1. Hamada S, Pionneau C, Parizot C, Silvie O, Chardonnet S, Marinach C. In-depth proteomic analysis of Plasmodium berghei sporozoites using trapped ion mobility spectrometry with parallel accumulation-serial fragmentation Proteomics :e2000305 2021 [PMID: 33452840]
  2. Ma R, Lian T, Huang R, Renn JP, Petersen JD, Zimmerberg J, Duffy PE, Tolia NH. Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA Nature microbiology 2021 [PMID: 33452495]
  3. Brunetti G, Padovani F, De Pastina A, Rotella C, Monahan A, Hoffman SL, Jongo SA, Abdulla S, Corradin G, Pluschke G, Daubenberger C, Hegner M. Nanotechnological immunoassay for rapid label-free analysis of candidate malaria vaccines Nanoscale 2021 [PMID: 33438712]
  4. Luo K, Gordy JT, Zavala F, Markham RB. A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques Scientific reports 11(1):1220 2021 [PMID: 33441615]
  5. Patel PN, Tolia NH. Structural vaccinology of malaria transmission-blocking vaccines Expert review of vaccines 2021 [PMID: 33430656]
  6. Nevagi RJ, Good MF, Stanisic DI. <i>Plasmodium</i> infection and drug cure for malaria vaccine development Expert review of vaccines 2021 [PMID: 33428505]
  7. Seidel-Greven M, Addai-Mensah O, Spiegel H, Chiegoua Dipah GN, Schmitz S, Breuer G, Frempong M, Reimann A, Klockenbring T, Fischer R, Barth S, Fendel R. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity Malaria journal 20(1):37 2021 [PMID: 33430886]
  8. Baral R, Levin A, Odero C, Pecenka C, Tabu C, Mwendo E, Bonsu G, Bawa J, Dadzie JF, Charo J, Antwi-Agyei KO, Amponsa-Achianou K, Jalango RE, Mkisi R, Gordon S, Mzengeza T, Morgan W, Muhib F. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries PloS one 16(1):e0244995 2021 [PMID: 33428635]
  9. Prahl M, Odorizzi P, Gingrich D, Muhindo M, McIntyre T, Budker R, Jagannathan P, Farrington L, Nalubega M, Nankya F, Sikyomu E, Musinguzi K, Naluwu K, Auma A, Kakuru A, Kamya MR, Dorsey G, Aweeka F, Feeney ME. Exposure to pesticides in utero impacts the fetal immune system and response to vaccination in infancy Nature communications 12(1):132 2021 [PMID: 33420104]
  10. Chaudhury S, MacGill RS, Early AM, Bolton JS, King CR, Locke E, Pierson T, Wirth DF, Neafsey DE, Bergmann-Leitner ES. Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine Vaccine 2021 [PMID: 33431225]
  11. Baisley KJ, Whitworth HS, Changalucha J, Pinto L, Dillner J, Kapiga S, de Sanjosé S, Mayaud P, Hayes RJ, Lacey CJ, Watson-Jones D. A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) - Study protocol for a randomised controlled trial Contemporary clinical trials 101:106266 2021 [PMID: 33421649]
  12. Asali S, Raz A, Turki H, Mafakher L, Razmjou E, Solaymani-Mohammadi S. Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases :104710 2021 [PMID: 33421653]
  13. Turner TC, Arama C, Ongoiba A, Doumbo S, Doumtabé D, Kayentao K, Skinner J, Li S, Traore B, Crompton PD, Götz A. Dendritic cell responses to Plasmodium falciparum in a malaria-endemic setting Malaria journal 20(1):9 2021 [PMID: 33407502]
  14. Barber NM, Lau CKY, Turner L, Watson G, Thrane S, Lusingu JPA, Lavstsen T, Higgins MK. Structure-Guided Design of a Synthetic Mimic of an Endothelial Protein C Receptor-Binding PfEMP1 Protein mSphere 6(1) 2021 [PMID: 33408232]
  15. Barsouk A, Thandra KC, Saginala K, Rawla P, Barsouk A. Chemical Risk Factors of Primary Liver Cancer: An Update Hepatic medicine : evidence and research 12:179-188 2020 [PMID: 33447099]
  16. Yimgang DP, Buchwald AG, Coalson JE, Walldorf JA, Bauleni A, Kapito-Tembo A, Mathanga DP, Taylor TE, Laufer MK, Cohee LM. Population Attributable Fraction of Anemia Associated with <i>P. falciparum</i> Infection in Children in Southern Malawi The American journal of tropical medicine and hygiene 2021 [PMID: 33399043]
  17. Ramharter M, Agnandji ST, Adegnika AA, Lell B, Mombo-Ngoma G, Grobusch MP, McCall M, Muranaka R, Kreidenweiss A, Velavan TP, Esen M, Schaumburg F, Alabi A, Druml C, Mordmüller B, Köhler C, Kremsner PG. Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon Wiener klinische Wochenschrift 2021 [PMID: 33398458]
  18. Mahaman Moustapha L, Adamou R, Ibrahim ML, Abdoulaye Louis Padounou M, Diallo A, Courtin D, Testa J, Ndiaye JLA. Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger Malaria journal 20(1):1 2021 [PMID: 33386070]
  19. Miyazaki Y, Marin-Mogollon C, Imai T, Mendes AM, van der Laak R, Sturm A, Geurten FJA, Miyazaki S, Chevalley-Maurel S, Ramesar J, Kolli SK, Kroeze H, van Schuijlenburg R, Salman AM, Wilder BK, Reyes-Sandoval A, Dechering KJ, Prudêncio M, Janse CJ, Khan SM, Franke-Fayard B. Generation of a Genetically Modified Chimeric <i>Plasmodium falciparum</i> Parasite Expressing <i>Plasmodium vivax</i> Circumsporozoite Protein for Malaria Vaccine Development Frontiers in cellular and infection microbiology 10:591046 2020 [PMID: 33392104]
  20. Abdusalam AAA, Murugaiyah V. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening Frontiers in molecular biosciences 7:603037 2020 [PMID: 33392261]
  21. Krzych U, Althubaiti N. The Form of an Antigen and Its Molecular Context Do Matter: Infectious versus Attenuated Plasmodium Sporozoites Critical reviews in immunology 40(4):311-323 2020 [PMID: 33426820]
  22. Nikolaeva D, Illingworth JJ, Miura K, Alanine DGW, Brian IJ, Li Y, Fyfe AJ, Da DF, Cohuet A, Long CA, Draper SJ, Biswas S. Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies Molecular & cellular proteomics : MCP 19(1):155-166 2020 [PMID: 33451551]

Salmonella

  1. Su H, Liu Q, Bian X, Wang S, Curtiss R 3rd, Kong Q. Synthesis and delivery of <i>Streptococcus pneumoniae</i> capsular polysaccharides by recombinant attenuated <i>Salmonella</i> vaccines Proceedings of the National Academy of Sciences of the United States of America 118(2) 2021 [PMID: 33380455]
  2. Dhingra D, Marathe SA, Sharma N, Marathe A, Chakravortty D. Modelling immune response to Salmonella during typhoid International immunology 2021 [PMID: 33406267]
  3. Jiang S, Noh J, Park C, Smith AD, Abbott NL, Zavala VM. Using machine learning and liquid crystal droplets to identify and quantify endotoxins from different bacterial species The Analyst 2021 [PMID: 33393547]
  4. Sztein MB, Bafford AC, Salerno-Goncalves R. Author Correction: Salmonella enterica serovar Typhi exposure elicits ex vivo cell-type-specific epigenetic changes in human gut cells Scientific reports 11(1):264 2021 [PMID: 33398004]
  5. Groves PJ, Williamson SL, Ahaduzzaman M, Diamond M, Ngo M, Han A, Sharpe SM. Can a combination of vaccination, probiotic and organic acid treatment in layer hens protect against early life exposure to Salmonella Typhimurium and challenge at sexual maturity? Vaccine 2020 [PMID: 33390293]
  6. Srinivasa Reddy Y, Narendra Babu K, Uday Kumar P, Harishankar N, Qadri SSYH, Surekha MV, Hemalatha R, Dinesh Kumar B. Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 &amp; 18): Regulatory toxicology studies in mice, rats and rabbits - An innovative approach Vaccine 2020 [PMID: 33388175]
  7. Cross DL, Verheul MK, Leipold MD, Obermoser G, Jin C, Jones E, Starr JS, Mohorianu I, Blohmke CJ, Maecker HT, Napolitani G, Hill J, Pollard AJ. Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever Frontiers in immunology 11:574057 2020 [PMID: 33424833]

Shigella

  1. Hajialibeigi A, Amani J, Gargari SLM. Identification and evaluation of novel vaccine candidates against Shigella flexneri through reverse vaccinology approach Applied microbiology and biotechnology 2021 [PMID: 33452891]
  2. de Alwis R, Liang L, Taghavian O, Werner E, The HC, Thu TNH, Duong VT, Davies DH, Felgner PL, Baker S. The identification of novel immunogenic antigens as potential Shigella vaccine components Genome medicine 13(1):8 2021 [PMID: 33451348]
  3. Mancini F, Gasperini G, Rossi O, Aruta MG, Raso MM, Alfini R, Biagini M, Necchi F, Micoli F. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA) Scientific reports 11(1):906 2021 [PMID: 33441861]
  4. Gozdziewicz TK, Maciejewska A, Tsybulska A, Lugowski C, Lukasiewicz J. A New Look at the Enterobacterial Common Antigen Forms Obtained during Rough Lipopolysaccharides Purification International journal of molecular sciences 22(2) 2021 [PMID: 33445776]

Variola major (Smallpox)

  1. Fassina A, Fassan M, Dosio GB, Barzon L. Triumphs and tribulations of COVID-19 vaccines: Lessons to be learned from smallpox epidemics in the 1700s Virchows Archiv : an international journal of pathology 2021 [PMID: 33432481]
  2. Liu Z, Nailwal H, Rector J, Rahman MM, Sam R, McFadden G, Chan FK. A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation Immunity 2021 [PMID: 33444549]
  3. Su JR, McNeil MM, Welsh KJ, Marquez PL, Ng C, Yan M, Cano MV. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018 Vaccine 2021 [PMID: 33422381]
  4. Pan Y, Liu L, Tian T, Zhao J, Park CO, Lofftus SY, Stingley CA, Yan Y, Mei S, Liu X, Kupper TS. Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge NPJ vaccines 6(1):1 2021 [PMID: 33398010]
  5. Opriessnig T, Mattei AA, Karuppannan AK, Halbur PG. Future perspectives on swine viral vaccines: where are we headed? Porcine health management 7(1):1 2021 [PMID: 33397477]
  6. Liu R, Americo JL, Cotter CA, Earl PL, Erez N, Peng C, Moss B. MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease bioRxiv : the preprint server for biology 2021 [PMID: 33442693]

Vibrio cholerae

  1. Sedaghat M, Siadat SD, Shahcheraghi F, Mirabzadeh Ardakani E, Keramati M, Vaziri F, Nojoumi SA. Assessment of Mouse Ileal loop Protection against Clinically Isolated Vibrio cholerae Outer Membrane Vesicles as a Vaccine Candidate Archives of Razi Institute 75(4):451-461 2021 [PMID: 33403840]

Yersinia pestis (Plague)

  1. Almeida JSFD, Botelho FD, de Souza FR, Dos Santos MC, Goncalves ADS, Rodrigues RLB, Cardozo M, Kitagawa DAS, Vieira LA, Silva RSF, Cavalcante SFA, Bastos LDC, Nogueira MOT, de Santana PIR, Brum JOC, Nepovimova E, Kuca K, LaPlante SR, Galante EBF, Franca TCC. Searching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets Journal of biomolecular structure & dynamics :1-14 2021 [PMID: 33416020]

Click HERE to see the publications in the last month.